MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration—Where Are We Now?

Autor: Ferreira, Mariana^1,2 (AUTHOR) mariana.f.ferreira@ipoporto.min-saude.pt, Morais, Mariana^1,2 (AUTHOR) mariana.gomes.morais@ipoporto.min-saude.pt, Medeiros, Rui^1,2,3,4,5 (AUTHOR) ruimedei@ipoporto.min-saude.pt, Teixeira, Ana Luísa¹ (AUTHOR) ana.luisa.teixeira@ipoporto.min-saude.pt

Publikováno v: Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1347. 23p.

Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia.

Autor: Stella, Michele¹ (AUTHOR) michele.stella@unict.it, Russo, Giorgio Ivan² (AUTHOR) giorgioivan.russo@unict.it, Leonardi, Rosario^3,4 (AUTHOR) leonardi.r@tiscali.it, Carcò, Daniela⁵ (AUTHOR) daniela.carco@grupposamed.com, Gattuso, Giuseppe⁶ (AUTHOR) peppeg9305@gmail.com, Falzone, Luca⁶ (AUTHOR) luca.falzone@unict.it, Ferrara, Carmen¹ (AUTHOR) carmen.ferrara@phd.unict.it, Caponnetto, Angela¹ (AUTHOR) angela.caponnetto@unict.it, Battaglia, Rosalia¹ (AUTHOR) rosalia.battaglia@unict.it, Libra, Massimo⁶ (AUTHOR) mlibra@unict.it, Barbagallo, Davide¹ (AUTHOR) dbarbaga@unict.it, Di Pietro, Cinzia¹ (AUTHOR) dipietro@unict.it, Pernagallo, Salvatore⁷ (AUTHOR) salvatore.pernagallo@destinagenomics.com, Barbagallo, Cristina¹ (AUTHOR) mragusa@unict.it, Ragusa, Marco¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10079. 22p.

A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia.

Autor: Martorana, Emanuele¹ (AUTHOR) emanuele.martorana@grupposamed.com, Raciti, Gabriele^1,2 (AUTHOR) gabriele.raciti@grupposamed.com, Giuffrida, Raffaella¹ (AUTHOR) raffaella.giuffrida@grupposamed.com, Bruno, Elena³ (AUTHOR) elena.bruno@dfa.unict.it, Ficarra, Vincenzo⁴ (AUTHOR) vficarra@unime.it, Ludovico, Giuseppe Mario⁵ (AUTHOR) giuseppeludovico@hotmail.com, Suardi, Nazareno Roberto⁶ (AUTHOR) suardi.nazareno@gmail.com, Iraci, Nunzio⁷ (AUTHOR) nunzio.iraci@unict.it, Leggio, Loredana⁷ (AUTHOR) loredana.leggio@unict.it, Bussolati, Benedetta⁸ (AUTHOR) benedetta.bussolati@unito.it, Grange, Cristina⁹ (AUTHOR) cristina.grange@unito.it, Lorico, Aurelio^1,10 (AUTHOR) alorico@touro.edu, Leonardi, Rosario¹¹ (AUTHOR) leonardi.r@tiscali.it, Forte, Stefano¹ (AUTHOR) stefano.forte@grupposamed.com

Publikováno v: Cells (2073-4409). Aug2024, Vol. 13 Issue 15, p1286. 18p.

DNA Methylation Markers for Breast Cancer Detection in the Developing World.

Autor: Downs BM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mercado-Rodriguez C; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Cimino-Mathews A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Chen C; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P.R. China., Yuan JP; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, P.R. China., Van Den Berg E; Department of Anatomical Pathology, University of Witwaterstrand and National Health Laboratory Service, Johannesburg, South Africa., Cope LM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Schmitt F; Medical Faculty of Porto University, Institute of Molecular Pathology and Immunology of Porto University, Porto, Portugal., Tse GM; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region., Ali SZ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Meir-Levi D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Sood R; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Li J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, P.R. China., Richardson AL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mosunjac MB; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia., Rizzo M; Department of Surgery, Emory University School of Medicine, Atlanta, Georgia., Tulac S; Cepheid, Sunnyvale, California., Kocmond KJ; Cepheid, Sunnyvale, California., de Guzman T; Cepheid, Sunnyvale, California., Lai EW; Cepheid, Sunnyvale, California., Rhees B; Cepheid, Sunnyvale, California., Bates M; Cepheid, Sunnyvale, California., Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Gabrielson E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Harvey SC; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Umbricht CB; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland., Visvanathan K; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Bloomberg School of Public Health, Baltimore, Maryland., Fackler MJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. saras@jhmi.edu facklma@jhmi.edu., Sukumar S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. saras@jhmi.edu facklma@jhmi.edu.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Nov 01; Vol. 25 (21), pp. 6357-6367. Date of Electronic Publication: 2019 Jul 12.

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer.

Autor: Gupta S; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Neumeister V; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA.; Indivumed Inc, Frederick, MD USA., McGuire J; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Song YS; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Acs B; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA.; 3Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Ho K; 4Division of Oncology Research and Development, Cepheid, Sunnyvale, CA USA., Weidler J; 5Medical and Scientific Affairs and Strategy, Oncology, Cepheid, Sunnyvale, CA USA., Wong W; 4Division of Oncology Research and Development, Cepheid, Sunnyvale, CA USA., Rhees B; 4Division of Oncology Research and Development, Cepheid, Sunnyvale, CA USA., Bates M; 5Medical and Scientific Affairs and Strategy, Oncology, Cepheid, Sunnyvale, CA USA., Rimm DL; 1Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Bossuyt V; 6Massachusetts General Hospital, Boston, MA USA.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2019 Aug 29; Vol. 5, pp. 28. Date of Electronic Publication: 2019 Aug 29 (Print Publication: 2019).